Kharazmi Shervin A, Kamat Pradip P, Simoneaux Stephen F, Simon Harold K
From the *Division of Emergency Medicine, Department of Pediatrics, Emory University School of Medicine; †Children's Healthcare of Atlanta; ‡Division of Pediatric Critical Care Medicine, Department of Pediatrics, §Department of Radiology and Imaging Sciences, and ∥Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
Pediatr Emerg Care. 2013 Sep;29(9):979-81. doi: 10.1097/PEC.0b013e3182a268d3.
Administration of PO contrast within 2 hours before sedation for abdominal computed tomography (CT) is controversial because it violates American Society of Anesthesiologists guidelines that recommend 2 hours of fasting for clear fluids before sedation.
This study aimed to review the administration of PO contrast for patients undergoing propofol sedation for abdominal CT and to evaluate the impact of violation of traditional 2-hour NPO guidelines on care.
Sedation records were reviewed from January 2010 to October 2011 from all patients who received PO contrast within 2 hours of propofol sedation for abdominal CT. A control group of patients receiving intravenous contrast only before propofol sedation and abdominal CT was reviewed. Demographics, time between PO contrast administration and sedation, and amount of PO contrast were recorded. Outcome measures including success of sedation and adverse events (vomiting, suctioning, use of O₂ or advanced airway, unplanned admissions) were recorded.
Eighty-five patients received PO contrast within 2 hours before sedation for abdominal CT; 21 controls were identified. No differences in demographics or outcome measures were seen. No significant differences were seen in rates of interventions or adverse outcomes between groups. Median time between the successive PO contrast doses and propofol administration was 1.6 hours and 0.6 hours.
Administering oral contrast material within 2 hours of propofol sedation for abdominal CT in children seems to be relatively safe compared with those sedated after traditional NPO time frames.
在腹部计算机断层扫描(CT)镇静前2小时内口服造影剂存在争议,因为这违反了美国麻醉医师协会的指南,该指南建议在镇静前2小时禁食清亮液体。
本研究旨在回顾接受丙泊酚镇静进行腹部CT检查的患者口服造影剂的情况,并评估违反传统2小时禁食指南对护理的影响。
回顾了2010年1月至2011年10月期间所有在丙泊酚镇静进行腹部CT检查前2小时内接受口服造影剂的患者的镇静记录。对仅在丙泊酚镇静和腹部CT检查前接受静脉造影剂的对照组患者进行了回顾。记录人口统计学资料、口服造影剂给药与镇静之间的时间以及口服造影剂的量。记录包括镇静成功率和不良事件(呕吐、吸引、使用氧气或高级气道、意外入院)在内的结果指标。
85例患者在腹部CT镇静前2小时内接受了口服造影剂;确定了21例对照组。在人口统计学或结果指标方面未见差异。两组之间在干预率或不良结局方面未见显著差异。连续口服造影剂剂量与丙泊酚给药之间的中位时间分别为1.6小时和0.6小时。
与在传统禁食时间框架后镇静的儿童相比,在丙泊酚镇静进行腹部CT检查前2小时内给予口服造影剂似乎相对安全。